Pharma & Life Sciences

Rare and Genetic Kidney Disease DD Summit

This summit is an industry-focused forum dedicated to advancing therapies for rare and inherited renal diseases. It covers drug development, mechanistic biology, clinical trial design, and patient recruitment. The event is for leading experts in discovery, translational, clinical, regulatory strategy, and patient engagement.

Official websiteRegisterAgenda
2 weeks until it opens.

The essentials

Event details

Dates
18 August 2026 to 20 August 2026
Location
Hotel Commonwealth, Boston, United States
Organiser
Hanson Wade
Industry
Pharma & Life Sciences

Agenda themes

Topics covered

  • Medical & Pharma

On stage

Speakers

  • Jennifer McKenzie, Senior Clinical Program Leader, Boehringer Ingelheim
  • Kristin Van Goor, Executive Director & US Head, Global Regulatory Policy & Innovation, Takeda
  • Savithri Kota, Director, Precision Nephrology, Bayer
  • Srini Srinivas, Senior Medical Director, Novartis
  • Manish Maski, Global Medical Affairs Exec Director, Vertex Pharmaceuticals
  • Vincent Ko, Founder & Executive Director, KidneyFuture
  • Rowland Elwell, Executive Medical Director, Nephrology, Calliditas
  • Jeff Sands, Chief Medical Officer, NephroDI
  • Joshua Waitzman, Senior Medical Director, Vera Therapeutics
  • Julie Lin, Travere Therapeutics

Logistics

Where to stay

Places to stay near the venue.

Keep planning

Related events

Spot something wrong on this page? Report a correction and we will fix it.